The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
Open accessAbstract
The prognostic value of epidermal growth factor receptor (EGF-R) for survival of patients with lung cancer remains controversial. The authors performed a systematic review of the literature in order to clarify its impact. Published studies were identified using an electronic search in order to aggregate the available survival results, after a methodological assessment using a scale specifically designed by the European Lung Cancer Working Party (ELCWP). To be eligible, a study had to have dealt with EGF-R assessment in lung cancer patients on the primary site and to have analysed survival according to EGF-R expression. Among the 16 eligible studies, 14 assessed any nonsmall-cell lung cancer (NSCLC) subtype, one adenocarcinoma only and one squamous-cell carcinoma only. The overall median quality score was 56.3%, with no significant difference either between studies assessable or not assessable for meta-analysis or between studies with significant and nonsignificant results. One individual trial reported a survival benefit for patients with EGF-R expression, three a survival disadvantage and 12 no statistically significant difference. Eleven studies (2,185 patients) provided sufficient data to allow a meta-analysis of the survival results. EGF-R expression positivity was determined according to the cut-off as determined by the authors. The meta-analysis showed that EGF-R expression was not a statistically significant prognostic factor for survival in NSCLC. In the subgroup of studies using immunohistochemistry, statistical tests reached a significant level against EGF-R. Epidermal growth factor receptor might be a poor prognostic factor for survival in nonsmall-cell lung cancer. The amplitude of the impact is small, however, and may be subject to publication bias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205 · cited 1×
“The individual HR estimates were combined into an overall HR using Peto9s method [8], which consisted of a fixed effect model assuming homogeneity of the individual true HRs.”
MethodProphylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
Aupérin, A., Arriagada, R., Pignon, J.-P., Le Péchoux, C., Gregor, A., Stephens, R. J., Kristjansen, P. E. G., Johnson, B. E., Ueoka, H., Wagner, H., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410703 · Cited by 1,718
Language bias in randomised controlled trials published in English and German
Egger, M., Zellweger-Zähner, T., Schneider, M., Junker, C., Lengeler, C., & Antes, G. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02419-7 · Cited by 1,028
The Medical Review Article: State of the Science
MULROW, C. D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3-485 · Cited by 856 · cited 1×
“The first approach is only based on fully published studies and provides an exhaustive and critical analysis of the topic with an adequate methodology based on the criteria of MULROW [35] and with data aggregation when possible.”
MethodMeta-analysis of the literature or of individual patient data: is there a difference?
Stewart, L. A., & Parmar, M. K. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)93004-k · Cited by 769
Rusch, V. W., Baselga, J. M., Cordon‐Cardo, C., Orazem, J. P., Zaman, M., Hoda, S. A., McIntosh, J., Kurie, J. M., & Dmitrovsky, E. (1993) · PubMed · Cited by 482
Brabender, J., Danenberg, K. D., Metzger, R., Schneider, P. M., Park, J., Salonga, D. S., Hölscher, A. H., & Danenberg, P. V. (2001) · PubMed · Cited by 452
Steels, E., Paesmans, M., Berghmans, T., Branle, F., Lemaitre, F., Mascaux, C., Meert, A. P., Vallot, F., Lafitte, J. J., & Sculier, J. P. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00062201 · Cited by 418
Self-citationRusch, V. W., Klimstra, D. S., Venkatraman, E. S., Pisters, P. W. T., Langenfeld, J. E., & Dmitrovsky, E. (1997) · PubMed · Cited by 401
The type 1 (EGFR-related) family of growth factor receptors and their ligands
Prigent, S. A., & Lemoine, N. R. (1992) · Progress in Growth Factor Research · doi:10.1016/0955-2235(92)90002-y · Cited by 369
Fontanini, G., Laurentiis, M. D., Vignati, S., Chinè, S., Lucchi, M., Silvestri, V., Mussi, A., Placido, S. D., Tortora, G., Bianco, A. R., et al. (1998) · PubMed · Cited by 306
Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
Pastorino, U., Andreola, S., Tagliabue, E., Pezzella, F., Incarbone, M., Sozzi, G., Buyse, M., Menard, S., Pierotti, M., & Rilke, F. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2858 · Cited by 302
Meert, A.-P., Paesmans, M., Berghmans, T., Martin, B., Mascaux, C., Vallot, F., Verdebout, J.-M., Lafitte, J.-J., & Sculier, J.-P. (2001) · BMC Cancer · doi:10.1186/1471-2407-1-5 · Cited by 281
Self-citationde Jong, J. S., van Diest, P. J., van der Valk, P., & Baak, J. P. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1<53::aid-path6>3.0.co;2-7 · Cited by 257
Ohsaki, Y., Tanno, S., Fujita, Y., Toyoshima, E., Fujiuchi, S., Nishigaki, Y., Ishida, S., Nagase, A., Miyokawa, N., Hirata, S., et al. (2000) · Oncology Reports · doi:10.3892/or.7.3.603 · Cited by 254
D'Amico, M., Massey, M., Herndon II, P., Moore, M.-B., & Harpole, D. H. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70294-1 · Cited by 233
Veale, D., Kerr, N., Gibson, G., Kelly, P., & Harris, A. L. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.306 · Cited by 219
Cox, G., Jones, J. L., & O'Byrne, K. J. (2000) · PubMed · Cited by 197
Volm, M., Rittgen, W., & Drings, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.106 · Cited by 178
Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.
Lee, J. S., Yoon, A., Kalapurakal, S. K., Ro, J. Y., Lee, J. J., Tu, N., Hittelman, W. N., & Hong, W. K. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.8.1893 · Cited by 163
Rusch, V. W., Klimstra, D. S., Linkov, I., & Dmitrovsky, E. (1995) · PubMed · Cited by 150
Do Molecular Markers Predict Survival in Non–Small-Cell Lung Cancer?
Greatens, T. M., Niehans, G. A., Rubins, J. B., Jessurun, J., Kratzke, R. A., Maddaus, M. A., & Niewoehner, D. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707108 · Cited by 104
Tateishi, M., Ishida, T., Kohdono, S., Hamatake, M., Fukuyama, Y., & Sugimachi, K. (1994) · Surgical Oncology · doi:10.1016/0960-7404(94)90006-x · Cited by 87
Potential role ofbcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer
Koukourakis, M. I., Giatromanolaki, A. N., O'Byrne, K. J., Whitehouse, R. M., Talbot, D. C., Gatter, K. C., & Harris, A. L. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971219)74:6<565::aid-ijc1>3.0.co;2-s · Cited by 63
Molecular and biological factors in the prognosis of non-small cell lung cancer
Kanters, S., Lammers, J. J., & Voest, E. E. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08081389 · Cited by 45
Meert, A., Berghmans, T., Branle, F., Lemaître, F., Mascaux, C., Rubesova, E., Vermylen, P., Paesmans, M., & Sculier, J. (1999) · PubMed · Cited by 22
Self-citation
Cited by
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
Self-citationErlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
Tsao, M.-S., Sakurada, A., Cutz, J.-C., Zhu, C.-Q., Kamel-Reid, S., Squire, J., Lorimer, I., Zhang, T., Liu, N., Daneshmand, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050736 · Cited by 1,830
Dissemination and publication of research findings: an updated review of related biases
Song, F., Parekh, Hooper, L., Loke, Y., Ryder, J., Sutton, A., Hing, C., Kwok, C., Pang, C., & Harvey, I. (2010) · Health Technology Assessment · doi:10.3310/hta14080 · Cited by 1,039
Gatzemeier, U., Pluzanska, A., Szczesna, A., Kaukel, E., Roubec, J., De Rosa, F., Milanowski, J., Karnicka-Mlodkowski, H., Pesek, M., Serwatowski, P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1474 · Cited by 881
Zhu, C.-Q., da Cunha Santos, G., Ding, K., Sakurada, A., Cutz, J.-C., Liu, N., Zhang, T., Marrano, P., Whitehead, M., Squire, J. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8924 · Cited by 661
Metadata
- Authors
- Meert, A.-P., Martin, B., Delmotte, P., Berghmans, T., Lafitte, J.-J., Mascaux, C., Paesmans, M., Steels, E., Verdebout, J.-M., & Sculier, J.-P.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2002-10
- Volume
- 20
- Issue
- 4
- Pages
- 975-981
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2101055110
- Cited by
- 264
- References
- 27
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.